Business Wire

Media Release: Jannik Sinner and Allianz Announce Multi-Year Global Partnership

29.1.2026 11:04:00 CET | Business Wire | Press Release

Share

Tennis star Jannik Sinner and Allianz Group announced a multi-year global partnership today, with the leading insurer and asset manager becoming an official partner of the four-time Grand Slam champion. Boasting approximately 300 million fans worldwide and a billion-strong ATP global fan base, tennis is the second-most popular sport behind football across Allianz key markets. A cornerstone of the collaboration is empowering children and youth through education and sport, providing them with enhanced opportunities for growth, health, and future success. This partnership also expands Allianz's involvement in sports, fostering awareness and emotional connections with people and customers in key Allianz markets.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260129184263/en/

Allianz Global Brand Ambassador, Jannik Sinner

At the heart of the partnership between the world’s most valuable insurance brand and the current No. 2 ATP tennis player Sinner, are joint values and a mutual belief in resilience and excellence – the ability to perform consistently at the highest level through disciplined preparation, mental strength, and a strong team. These principles are central to Sinner’s sports mindset and align with Allianz’s dedication to supporting people and organizations through defining moments, securing their future and building confidence in tomorrow.

Jannik Sinner said: “I am delighted to announce this partnership with Allianz. Over the years I have learned that success in sport, as in life, is forged through resilience, preparation, and the willingness to push yourself beyond your comfort zone. A strong team drives every achievement – they push and support me, working hard day after day in order to improve both on and off the court. I know Allianz shares that vision, and I look forward to building a collaboration with them, especially through the partnership with my Foundation.”

Oliver Bäte, Chief Executive Officer of Allianz SE, said: “At Allianz, trust is at the heart of our mission to empower individuals and organizations for a brighter future. We're thrilled to partner with Jannik, whose values of authenticity, resilience, and excellence mirror our own. This collaboration enhances our established sports partnerships and underscores our dedication to nurturing the potential of the next generation, empowering children and youth to face a changing world with confidence and optimism. Together, we build a future grounded in trust and shared success.”

Giacomo Campora, Allianz Italy’s CEO, commented: “Allianz Italy is proud to support an extraordinary Italian champion like Jannik Sinner. He is worldwide appreciated not only as an athlete, but as a role model of sportsmanship, simplicity, style, and determination to achieve his goals. The constant pursuit of excellence to which Jannik aspires is the same that drives the people at Allianz in their daily work. Today we begin this journey alongside him, aiming to grow together with him.”

The tagline “We're here to serve” encapsulates the unified spirit and values of Allianz and Jannik Sinner. This message will be prominently showcased in campaigns with Sinner as the Allianz Global Brand Ambassador, reaching customers, employees, distribution partners, and fans worldwide. The collaboration also extends to Allianz’s support for The Jannik Sinner Foundation, promoting programs that leverage education and sport to empower children to explore the world and their place within it.

Allianz boosts Sinner’s portfolio of global partners, which includes brands such as Rolex, Nike, Gucci, Lavazza, and Explora Journeys. Sinner enters 2026 on the back of a standout 2025 season in which he won six titles including the Australian Open, Wimbledon, and the ATP Finals, while reaching the finals of all four Grand Slam tournaments.

Allianz’s sport partnerships

Allianz has been a partner of the Olympic and Paralympic Movements since 2021 and will continue until 2032, playing a key role as the The Official Insurer for the upcoming Milano Cortina 2026 Olympic and Paralympic Winter Games. For more than 25 years, Allianz has partnered with FC Bayern München and also collaborates with hundreds of local sports clubs and associations in its national markets. As part of its Power of Unity positioning and program, Allianz believes in the power of sports to unite millions of athletes and fans in peaceful competitions and to transcend social and cultural barriers, which is ever more important in an increasingly divided and polarized world.

Further links

Jannik Sinner’s website

The Jannik Sinner Foundation Allianz Partnerships

Power of Unity

About the Jannik Sinner Foundation

Founded in 2025, the Jannik Sinner Foundation believes that education and sport can transform a child’s life. Inspired by the people and opportunities that shaped Jannik Sinner’s own journey, the Foundation partners with trusted global and local organizations to remove barriers and provide children worldwide with access to education and sport.

It supports educational programs and sports initiatives that foster personal growth and empower children to thrive mentally and physically, helping them reach their full potential while embracing healthy, active lifestyles.

For more information, visit: www.janniksinnerfoundation.org.

About Allianz

The Allianz Group is one of the world's leading insurers and asset managers serving private and corporate customers in nearly 70 countries. Allianz customers benefit from a broad range of personal and corporate insurance services, ranging from property, life and health insurance to assistance services to credit insurance and global business insurance. Allianz is one of the world’s largest investors, managing around 761 billion euros* on behalf of its insurance customers. Furthermore, our asset managers PIMCO and Allianz Global Investors manage about 1.9 trillion euros* of third-party assets. Thanks to our systematic integration of ecological and social criteria in our business processes and investment decisions, we are among the leaders in the insurance industry in the Dow Jones Sustainability Index. In 2024, over 156,000 employees achieved total business volume of 179.8 billion euros and an operating profit of 16.0 billion euros for the Group.

*As of September 30, 2025.

Mandatory corporate information: Corporate disclosures

These assessments are, as always, subject to the disclaimer provided below.

Cautionary note regarding forward-looking statements

This document includes forward-looking statements, such as prospects or expectations, that are based on management's current views and assumptions and subject to known and unknown risks and uncertainties. Actual results, performance figures, or events may differ significantly from those expressed or implied in such forward-looking statements.

Deviations may arise due to changes in factors including, but not limited to, the following: (i) the general economic and competitive situation in the Allianz’s core business and core markets, (ii) the performance of financial markets (in particular market volatility, liquidity, and credit events), (iii) adverse publicity, regulatory actions or litigation with respect to the Allianz Group, other well-known companies and the financial services industry generally, (iv) the frequency and severity of insured loss events, including those resulting from natural catastrophes, and the development of loss expenses, (v) mortality and morbidity levels and trends, (vi) persistency levels, (vii) the extent of credit defaults, (viii) interest rate levels, (ix) currency exchange rates, most notably the EUR/USD exchange rate, (x) changes in laws and regulations, including tax regulations, (xi) the impact of acquisitions including related integration issues and reorganization measures, and (xii) the general competitive conditions that, in each individual case, apply at a local, regional, national, and/or global level. Many of these changes can be exacerbated by terrorist activities.

No duty to update

Allianz assumes no obligation to update any information or forward-looking statement contained herein, save for any information we are required to disclose by law.

Privacy Note

Allianz SE is committed to protecting your personal data. Find out more in our privacy statement.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260129184263/en/

Contacts

For further information about Allianz please contact:
Lauren Day
Tel. +49 89 3800 3345
E-Mail: lauren.day@allianz.com

Florian Amberg
Tel. +49 89 3800 15924
E-Mail: florian.amberg@allianz.com

Heidi Polke
Tel. +49 89 3800 90777
E-Mail: heidi.polke@allianz.com

For further information about Jannik Sinner please contact:
Fabienne Benoit
E-Mail: press@avima.com

Sam Postlethwaite
E-Mail: sam.postlethwaite@edelman.com

Ben Machon
E-Mail: ben.machon@assemblyinc.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte’s Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi ® /Minjuvi ® ) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL30.5.2026 14:00:00 CEST | Press Release

Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, and lenalidomide added to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone; Tafa-Len-R-CHOP) versus R-CHOP alone as a first-line treatment for adults with previously untreated diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL). Eligible patients had an International Prognostic Index (IPI) score of 3-5, or, for patients ≤60 years of age, an age-adjusted IPI (aaIPI) of 2-3. The oral presentation of these data is taking place at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting being held May 29 – June 2, 2026, in Chicago (Abstract #LBA7000. Session: Oral Abstract Session – Hematologic Malignancies – Lymphoma and Chronic Lymphocytic Leukemia. May 30, 4:00 – 7:00 p.m. ET [3:00 – 6:00 p.m.

Fortegra Completes Acquisition by DB Insurance29.5.2026 22:30:00 CEST | Press Release

The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a

SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 22:01:00 CEST | Press Release

Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.

From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press Release

NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under 20 minutes, saving hundreds of hours of engineer time, shrinking MTTR by more than 95%. A global telecommunications firm found NetBrain's context-grounded agents outperformed a stand-alone frontier LLM on a persistent firewall

Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press Release

Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consistent approach to protecting our innovation and our customers,” said Justin Ferguson, SVP and general counsel at Adtran. “We take all claims seriously, but we will not hesitate to defend ourselves when assertions lack merit. Situations like this place unnecessary strain on technology providers and divert resources from advancing networks and services. By advancing our counterclaim

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye